In contrast to cell lines and organoids, the potent and selective TTK inhibitor NTRC 0066-0 had no effect on the viability of non-dividing cells derived from pediatric T-ALL, which were efficiently killed by chemotherapeutic agents. Here, TTK is linked to acute lymphoblastic leukemia.